These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 31246975)
1. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides. Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975 [TBL] [Abstract][Full Text] [Related]
2. Discovery, cloning and characterisation of proline specific prolyl endopeptidase, a gluten degrading thermo-stable enzyme from Sphaerobacter thermophiles. Shetty R; Vestergaard M; Jessen F; Hägglund P; Knorr V; Koehler P; Prakash HS; Hobley TJ Enzyme Microb Technol; 2017 Dec; 107():57-63. PubMed ID: 28899487 [TBL] [Abstract][Full Text] [Related]
3. Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract. Zamakhchari M; Wei G; Dewhirst F; Lee J; Schuppan D; Oppenheim FG; Helmerhorst EJ PLoS One; 2011; 6(9):e24455. PubMed ID: 21957450 [TBL] [Abstract][Full Text] [Related]
4. Development of wheat genotypes expressing a glutamine-specific endoprotease from barley and a prolyl endopeptidase from Flavobacterium meningosepticum or Pyrococcus furiosus as a potential remedy to celiac disease. Osorio CE; Wen N; Mejias JH; Liu B; Reinbothe S; von Wettstein D; Rustgi S Funct Integr Genomics; 2019 Jan; 19(1):123-136. PubMed ID: 30159724 [TBL] [Abstract][Full Text] [Related]
5. Efficient Hydrolysis of Gluten-Derived Celiac Disease-Triggering Immunogenic Peptides by a Bacterial Serine Protease from Liu YY; Lee CC; Hsu JH; Leu WM; Meng M Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33802942 [TBL] [Abstract][Full Text] [Related]
6. Selective capture of most celiac immunogenic peptides from hydrolyzed gluten proteins. Moreno Mde L; Muñoz-Suano A; López-Casado MÁ; Torres MI; Sousa C; Cebolla Á Food Chem; 2016 Aug; 205():36-42. PubMed ID: 27006211 [TBL] [Abstract][Full Text] [Related]
7. Human small-intestinal gluten-degrading bacteria and its potential implication in celiac disease. Dewala S; Bodkhe R; Nimonkar Y; Prakash OM; Ahuja V; Makharia GK; Shouche YS J Biosci; 2023; 48():. PubMed ID: 37309172 [TBL] [Abstract][Full Text] [Related]
8. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes. Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911 [TBL] [Abstract][Full Text] [Related]
9. Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease. Wei G; Tian N; Valery AC; Zhong Y; Schuppan D; Helmerhorst EJ Am J Gastroenterol; 2015 Jun; 110(6):899-908. PubMed ID: 25895519 [TBL] [Abstract][Full Text] [Related]
10. Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy. Gass J; Ehren J; Strohmeier G; Isaacs I; Khosla C Biotechnol Bioeng; 2005 Dec; 92(6):674-84. PubMed ID: 16136593 [TBL] [Abstract][Full Text] [Related]
11. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427 [TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity. Helmerhorst EJ; Zamakhchari M; Schuppan D; Oppenheim FG PLoS One; 2010 Oct; 5(10):e13264. PubMed ID: 20948997 [TBL] [Abstract][Full Text] [Related]
14. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue. Gass J; Bethune MT; Siegel M; Spencer A; Khosla C Gastroenterology; 2007 Aug; 133(2):472-80. PubMed ID: 17681168 [TBL] [Abstract][Full Text] [Related]
15. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients. Tian N; Faller L; Leffler DA; Kelly CP; Hansen J; Bosch JA; Wei G; Paster BJ; Schuppan D; Helmerhorst EJ Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28087531 [TBL] [Abstract][Full Text] [Related]
16. Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization. Marti T; Molberg O; Li Q; Gray GM; Khosla C; Sollid LM J Pharmacol Exp Ther; 2005 Jan; 312(1):19-26. PubMed ID: 15358813 [TBL] [Abstract][Full Text] [Related]
17. Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease. Wei G; Tian N; Siezen R; Schuppan D; Helmerhorst EJ Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G571-80. PubMed ID: 27469368 [TBL] [Abstract][Full Text] [Related]
18. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease. Stepniak D; Spaenij-Dekking L; Mitea C; Moester M; de Ru A; Baak-Pablo R; van Veelen P; Edens L; Koning F Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G621-9. PubMed ID: 16690904 [TBL] [Abstract][Full Text] [Related]
19. Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion. Francavilla R; De Angelis M; Rizzello CG; Cavallo N; Dal Bello F; Gobbetti M Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500039 [TBL] [Abstract][Full Text] [Related]